The Relationship between the Leptin Concentration and the Small Dense Low Density Lipoprotein Cholesterol Concentration in Korean Type 2 Diabetic Patients

Background: Leptin has been suggested as a possible cause of atherosclerotic disease. The small dense low-density lipoprotein cholesterol (LDL-C) has also been regarded as a new surrogate marker in atherosclerotic disease. The aim of this study was to evaluate the relationship between the leptin concentration and the small dense LDL-C concentration in Korean type 2 diabetic patients. Methods: One hundred-ninety one type 2 diabetic patients, who did not use any medication that could affect the concentration of lipid such as statin, fibrate, thiazolidinediones and corticosteroid, were enrolled in this study. We analyzed the relationship between leptin, the small dense LDL-C and the other metabolic parameters. Results: The small dense LDL-C concentrations were higher in the group with the highest tertile of the leptin value, both in males and females than those patients in the group with the lowest tertile of the leptin value. The small dense LDL-C concentrations were also higher in the group with the highest tertile of leptin divided by the BMI value both in males and females than those patients in the group with the lowest tertile of the leptin value. The leptin concentration was positively correlated with the small dense LDL-C, total cholesterol, triglyceride, LDL-C, insulin and HOMAIR values after adjusting for age, gender and BMI. Conclusion: The association between leptin and small dense LDL-C could be a factor that explains the association between leptin and cardiovascular disease. (J Kor Soc Endocrinol 21:319~327, 2006)

[1]  Bruce D. Johnson,et al.  Plasma leptin and prognosis in patients with established coronary atherosclerosis. , 2004, Journal of the American College of Cardiology.

[2]  L. Weinehall,et al.  Leptin, but not adiponectin, predicts stroke in males , 2004, Journal of internal medicine.

[3]  M. Di Nisio,et al.  Circulating leptin is associated with oxidized LDL in postmenopausal women. , 2004, Atherosclerosis.

[4]  S. Koba,et al.  Clinical Significance of Small Dense Low-Density Lipoprotein Cholesterol Levels Determined by the Simple Precipitation Method , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[5]  L. Luzi,et al.  Fasting plasma leptin, tumor necrosis factor-alpha receptor 2, and monocyte chemoattracting protein 1 concentration in a population of glucose-tolerant and glucose-intolerant women: impact on cardiovascular mortality. , 2003, Diabetes care.

[6]  J. Dekker,et al.  Associations of LDL size with in vitro oxidizability and plasma levels of in vivo oxidized LDL in Type 2 diabetic patients , 2003, Diabetic medicine : a journal of the British Diabetic Association.

[7]  N. Sattar,et al.  Plasma Leptin and the Risk of Cardiovascular Disease in the West of Scotland Coronary Prevention Study (WOSCOPS) , 2001, Circulation.

[8]  S. Koschnick,et al.  Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity. , 2001, The Journal of clinical investigation.

[9]  Y. Kaneda,et al.  Leptin Induces Mitochondrial Superoxide Production and Monocyte Chemoattractant Protein-1 Expression in Aortic Endothelial Cells by Increasing Fatty Acid Oxidation via Protein Kinase A* , 2001, The Journal of Biological Chemistry.

[10]  M. Yokoyama,et al.  Leptin stimulates rat aortic smooth muscle cell proliferation and migration. , 2001, The Kobe journal of medical sciences.

[11]  F. Parhami,et al.  Leptin Enhances the Calcification of Vascular Cells: Artery Wall as a Target of Leptin , 2001, Circulation research.

[12]  E. Rimm,et al.  Glycemic status and soluble tumor necrosis factor receptor levels in relation to plasma leptin concentrations among normal weight and overweight US men , 2000, International Journal of Obesity.

[13]  N. Abate.  Obesity and cardiovascular disease. Pathogenetic role of the metabolic syndrome and therapeutic implications. , 2000, Journal of diabetes and its complications.

[14]  P. Zimmet,et al.  Etiology of the Metabolic Syndrome: Potential Role of Insulin Resistance, Leptin Resistance, and Other Players , 1999, Annals of the New York Academy of Sciences.

[15]  T. Olsson,et al.  Leptin is associated with increased risk of myocardial infarction , 1999, Journal of internal medicine.

[16]  M. Laakso,et al.  Is leptin concentration associated with the insulin resistance syndrome in nondiabetic men? , 1999, Obesity Research.

[17]  L. Weinehall,et al.  Leptin is a risk marker for first-ever hemorrhagic stroke in a population-based cohort. , 1999, Stroke.

[18]  J. Halaas,et al.  Leptin and the regulation of body weight in mammals , 1998, Nature.

[19]  R. Deckelbaum,et al.  Small dense low density lipoprotein has increased affinity for LDL receptor-independent cell surface binding sites: a potential mechanism for increased atherogenicity. , 1998, Journal of lipid research.

[20]  G. Dagenais,et al.  Leptinemia Is Not a Risk Factor for Ischemic Heart Disease in Men: Prospective results from the Quebec Cardiovascular Study , 1998, Diabetes Care.

[21]  J. Tuomilehto,et al.  Is there a relationship between leptin and insulin sensitivity independent of obesity?A population-based study in the Indian Ocean nation of Mauritius , 1998, International Journal of Obesity.

[22]  A. Mark,et al.  Receptor-mediated regional sympathetic nerve activation by leptin. , 1997, The Journal of clinical investigation.

[23]  R. Considine,et al.  Leptin: The Tale of an Obesity Gene , 1996, Diabetes.

[24]  J. Hokanson,et al.  Compositional differences of LDL particles in normal subjects with LDL subclass phenotype A and LDL subclass phenotype B. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[25]  G. Bondjers,et al.  Accumulation of lipoprotein fractions and subfractions in the arterial wall, determined in an in vitro perfusion system. , 1996, Atherosclerosis.

[26]  R. Considine,et al.  Serum immunoreactive-leptin concentrations in normal-weight and obese humans. , 1996, The New England journal of medicine.

[27]  J. Naggert,et al.  Atherosclerosis in genetically obese mice: the mutants obese, diabetes, fat, tubby, and lethal yellow. , 1994, Metabolism: clinical and experimental.

[28]  C. Packard,et al.  Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk. , 1994, Atherosclerosis.

[29]  J. Hendriks,et al.  Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[30]  W C Willett,et al.  Low-density lipoprotein subclass patterns and risk of myocardial infarction. , 1988, JAMA.

[31]  A. Sniderman,et al.  Metabolic basis of hyperapobetalipoproteinemia. Turnover of apolipoprotein B in low density lipoprotein and its precursors and subfractions compared with normal and familial hypercholesterolemia. , 1986, The Journal of clinical investigation.

[32]  J. Allan,et al.  Dissociation of obesity, hypercholesterolemia and diabetes from atherosclerosis in ob/ob mice , 1977, Experientia.

[33]  T. Katagiri,et al.  Remarkably high prevalence of small dense low-density lipoprotein in Japanese men with coronary artery disease, irrespective of the presence of diabetes. , 2002, Atherosclerosis.

[34]  Teven,et al.  MORTALITY FROM CORONARY HEART DISEASE IN SUBJECTS WITH TYPE 2 DIABETES AND IN NONDIABETIC SUBJECTS WITH AND WITHOUT PRIOR MYOCARDIAL INFARCTION , 2000 .

[35]  J. Hall,et al.  Chronic leptin infusion increases arterial pressure. , 1998, Hypertension.

[36]  J. Tuomilehto,et al.  Is there a relationship between leptin and insulin sensitivity independent of obesity? A population-based study in the Indian Ocean nation of Mauritius. Mauritius NCD Study Group. , 1998, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.